DEKRA to acquire Chilworth Global

Published: 16-Aug-2011
Hi Tech Manufacturing Regulatory Analysis

Will become a leading international provider of quality and safety services


DEKRA is to buy Chilworth Global, an explosion protection and process safety service company based in Southampton, UK, for an undisclosed sum.

DEKRA, headquartered in Stuttgart, Germany, says the move will make the company a leading international provider of quality and safety services.

Employing around 160 people, Chilworth Global has annual sales of around €15m. It operates testing laboratories in the UK, US and has branch offices in India, France, Italy and Spain. It offers material testing, consulting and training services for the process industries, with an emphasis on the chemical, pharmaceutical and food industry sectors.

Chilworth Global will be assigned to DEKRA’s Product Testing and Certification operation and will work with the laboratories of the DEKRA Certification Group in Arnhem, the Netherlands, and DEKRA EXAM in Bochum, Germany, where DEKRA’s explosion protection activities are based.

‘The pairing of Chilworth Global and DEKRA is a decisive step in DEKRA's strategy to expand the industrial business with high-quality expert services in the process industries on a global scale,’ said Stefan Kölbl, chairman of DEKRA eV and DEKRA SE.

‘We are decisively expanding our position in the UK and the important markets in India and North America and are establishing a further strategic platform for the development of markets in Asia and the American continent.’

In the future, Paul Cartwright, ceo and one of the founders of Chilworth Global, and Bert Zoetbrood, ceo of the DEKRA Certification Group in Arnhem, the Netherlands will head Chilworth Global.

‘DEKRA is the ideal partner for Chilworth Global in order to further develop the company within the worldwide DEKRA network and to provide exciting opportunities for our highly skilled and valued staff,’ said Cartwright.

  • Companies:
  • Chilworth Global
  • DEKRA
See more

You may also like

Hi Tech Manufacturing

New chillers for laboratories

Read more
Expansion of the Minichiller range with more powerful models

Trending Articles

  1. Overcoming CMC challenges in cell and gene therapy: part I Certara’s Dr Hien Anh Bruno, Associate Director, Chemistry, Manufacturing and Controls (CMC), and Dr Deven Shah, CMC Lead, propose mitigation strategies to address the CMC challenges inherent in producing cell and gene therapy (CGT) drugs
  2. The rising importance of preservative efficacy testing When considering the regulation and validation of pharmaceutical products, the efficacy of the active pharmaceutical ingredient (API) is often the main concern
  3. Tagrisso receives full approval in the EU For patients with locally-advanced or metastatic EGFR T790M mutation-positive non-small cell lung cancer
  4. Huber Huber Kältemaschinenbau SE is the technology leader for high precision thermoregulation solutions in research and industry. Huber products ensure precise temperature control throughout the whole world in laboratories, pilot plants and production processes. Our product range offers temperature control solutions for applications from -125°C to +425°C.

Upcoming event

Lounges

23-25 April 2024 | Conference | Messe Karlsruhe, Germany See all

You may also like

Hi Tech Manufacturing

New chillers for laboratories

Expansion of the Minichiller range with more powerful models
Regulatory

Overcoming CMC challenges in cell and gene therapy: part II

Certara’s Dr Hien Anh Bruno, Associate Director, Chemistry, Manufacturing and Controls (CMC), and Dr Deven Shah, CMC Lead, propose mitigation strategies to address the CMC challenges inherent in producing cell and gene therapy (CGT) drugs
Regulatory

Overcoming CMC challenges in cell and gene therapy: part I

Certara’s Dr Hien Anh Bruno, Associate Director, Chemistry, Manufacturing and Controls (CMC), and Dr Deven Shah, CMC Lead, propose mitigation strategies to address the CMC challenges inherent in producing cell and gene therapy (CGT) drugs
Regulatory

AskBio receives FDA Fast Track Designation for congestive heart failure gene therapy programme

The fast-tracking allows the development and expedition of review processes for AB-1002, a gene therapy to promote production of a constituently active form of I-1c
Analysis

Beckman introduces novel CE-Marked Hepatitis Assays at ESCMID Global

The HBsAg high positive algorithm eliminates the need for repeat and confirmatory testing for samples ≥ 100.00 S/CO
Manufacturing

Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success

Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for successful market entry from the early stages of development, reports Frederick Duynslaeger, Senior CMC Writer at Ardena
Analysis

Titan Enterprises’ 800-series turbine flow meters provide a low-cost solution for the pharmaceutical industry

Titan's flowmeters can assist in accurate batch delivery and dispensing systems for low viscosity liquids for incorporation in ingestible pharmaceutical products
Subscribe now